Agilent Technologies Inc.
The company was founded in 1999, headquarter in California, U.S. The company provides laboratories worldwide with instruments, services, consumables, application and expertise, enabling customers to gain the insights they seek. The main business segments of the company are life sciences and applied markets, diagnostics and genomics, Agilent cross lab. The revenue of the company in 2018 was USD 3,620.0 Million. Number of employees in 2018(July 31) was 14,500. The company has global presence in Americas, Europe, Africa, Asia-Pacific and Middle East.
In 2018, Agilent Technologies, Inc. completed acquisition of ACEA Biosciences (U.S.). This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses.
Waters was founded in 1958 and headquartered at Massachusetts, U.S. The company is engaged in safety of the world’s food and drinking water supplies, monitoring and controlling pollution, conserving the world’s greatest art treasure, scientists worldwide rely on Waters liquid chromatography and mass spectrometry products. The main business segments are Waters instrument systems, chemistry consumables and Waters services. The market focused segment is columns and chromatography. The total numbers of employees are 7,000. The revenue of the company in 2018 was USD 1704.91 Million. The company has global presence in North America, Europe, Asia-Pacific and Middle East and Africa.
In 2017, Waters announced that Brazil's National Health Surveillance Agency (ANVISA) has approved the Waters ACQUITY UPLC, ACQUITY UPLC I-Class System. The Clinical laboratories have the access to enhance the levels of sensitivity, selectivity, and versatility from Waters' newest UPLC-MS/MS technologies.
Founded in 1937 and headquartered in Massachusetts, U.S. The company is involved in providing products, services, and solutions to the diagnostics, research, environment, industrial, food and laboratory services market worldwide. The main business segments of the company are diagnostic and discovery and analytical solution. The market focused segment is instruments and consumables. The revenue of the company in 2018 was USD 2,021.64 Million. The company has global presence in North America, Europe, Asia-Pacific, Middle East and Africa and South America.
In 2018, PerkinElmer Inc. acquired Shanghai Spectrum Instruments Co., Ltd.( China). This acquisition will helps to build upon the China presence through SSI’s strong localized market position while further solidifying PerkinElmer’s leadership is seen in Atomic Absorption technologies.